Mithra Pharmaceuticals: AGREES EXCLUSIVE LONG-TERM LICENSE AND SUPPLY AGREEMENT WITH MAYNE PHARMA TO COMMERCIALIZE MYRING(TM) IN THE US
28 févr. 2017 01h00 HE | Mithra Pharmaceuticals
PRESS RELEASE Mithra agrees Exclusive LONG-TERM license and supply agreement with Mayne Pharma to commercialize Myring(TM) in the US               Mithra grants its first exclusive license...
Mithra Pharmaceuticals: MITHRA GRANTED EUR 1.9 MILLION IN NON-DILUTIVE FUNDING
13 févr. 2017 06h00 HE | Mithra Pharmaceuticals
PRESS RELEASE MITHRA granted eur 1.9 million in non-dilutive funding Non-dilutive funding granted by the Walloon region Funding to support Estetrol (E4) and complex therapeutics solutions...
MITHRA COMPLETES RECRUITMENT FOR EUROPEAN PHASE III ESTELLE® STUDY
07 févr. 2017 01h30 HE | Mithra Pharmaceuticals
PRESS RELEASE MITHRA COMPLETES RECRUITMENT FOR European phase iii estelle® study Liège, Belgium, 07 February 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on...
Mithra Pharmaceuticals: MITHRA STRENGTHENS POSITION IN THE BELGIAN CONTRACEPTION MARKET
31 janv. 2017 01h30 HE | Mithra Pharmaceuticals
PRESS RELEASE Mithra Strengthens Position in the Belgian Contraception Market Mithra builds on leading position in Belgian contraceptive market Mithra achieves significant increase in 2016...
Mithra Pharmaceuticals: Mithra plans to submit Myring for US and EU approval in Q2 2017
24 janv. 2017 01h30 HE | Mithra Pharmaceuticals
PRESS RELEASE Mithra plans to submit myring for us and eu approval in q2 2017 Planned submissions follow successful trials demonstrating bioequivalence to NuvaRing® Liège, Belgium, 24...
MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE
18 janv. 2017 01h30 HE | Mithra Pharmaceuticals
PRESS RELEASE MITHRA ANNOUNCES US PATENT ALLOWANCE FOR THE USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE Liège, Belgium, 18 January 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a...
Mithra Pharmaceuticals: MITHRA'S NORTH AMERICAN ADVISORY BOARD FOR DONESTA® WILL MEET IN MIAMI, FLORIDA THE 20TH- 21ST JANUARY 2017
12 janv. 2017 08h02 HE | Mithra Pharmaceuticals
PRESS RELEASE Mithra's North american Advisory Board for Donesta® will meet in miami, Florida the 20th- 21st January 2017 Mithra has set up scientific advisory boards composed of...
Mithra Pharmaceuticals: MITHRA'S NORTH AMERICAN ADVISORY BOARD FOR DONESTA® WILL MEET IN MIAMI, FLORIDA THE 20TH- 21ST JANUARY 2017
12 janv. 2017 01h30 HE | Mithra Pharmaceuticals
PRESS RELEASE Mithra's North american Advisory Board for Donesta® will meet in miami, Florida the 20th- 21st January 2017 Mithra has set up scientific advisory boards composed of international...
Mithra Pharmaceuticals: APPOINTMENT OF CHRISTOPHE MARÉCHAL AS CHIEF FINANCIAL OFFICER
06 janv. 2017 12h31 HE | Mithra Pharmaceuticals
PRESS RELEASE Appointment of CHRISTOPHE MarÉchal AS chief financial officer Liège, Belgium, 6 January 2017 - Mithra Pharmaceuticals (Euronext Brussels: MITRA), a company focused on women's...
Mithra Pharmaceuticals: MITHRA LAUNCHES ITS PRODUCT TIBELIA ON THE GLOBAL MARKET
22 déc. 2016 08h13 HE | Mithra Pharmaceuticals
                                                                                                                                                         PRESS RELEASE Mithra launches ITS...